Editor’s Note – January 2015

Editor’s Note Martha from Virginia recently wrote saying, “I know I should exercise and have made it my number one resolution.” We hope you achieve your goal, Martha! The three things on our goal list are to educate, empower and encourage you to continue to enjoy life despite obstacles that you may have to overcome.…

Respiratory News – January 2015

Respiratory News  Authors evaluated the efficacy of a e1e2k­woral  treatment  with  azithromycin in adults with bronchiectasis. They concluded that 12 ­week administration of azithromycin produces significant reductions in sputum volume, health status and stabilization of lung function values. Sputum volume reduction and the improvement of quality of life were sustained for 12 weeks after cessation…

Respiratory News-November-2014

    Respiratory News Treatment with 400 mcg Tudorza Pres- sair – aclidinium bromide inhalation powder  daily over a year-long period appears to bring relief of symptoms associated with COPD. Findings were presented at the 2014 Annual Meeting of the American College of Chest Physicians. An FDA advisory committee voted that Varenicline (Chantix), a drug…

Calling Dr. Bauer -November-2014

    Calling Dr. Bauer As 2014 draws to a close, I thought this would be a good  opportunity to give our readers a brief update on what’s new in the world of pulmonary medicine. Here we go: Lung Cancer: We are discovering new proteins called driver mutations on the surface of lung cancer cells…